http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2015200721-B2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ba957a02fb77c238cdddf606248e01d |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-78 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-405 |
filingDate | 2015-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2017-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27509e5d9c86f75a1c3ef775efb5a8ad http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e10025b172cb6bb360f25884c07a50fc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_555287e1486bb8bec33e3ed1ff52c6e7 |
publicationDate | 2017-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | AU-2015200721-B2 |
titleOfInvention | Compositions and methods for inhibiting cytochrome P450 2D6 |
abstract | Hi:\szp\lnIenvoven\NRPortbl\DCC\SZP\745035i7_ Ldocs9/02/20 15 Methods of inhibiting cytochrome P450 2D6 enzymes are provided that can be used for improving the treatment of diseases by preventing degradation of drugs or other molecules by cytochrome P450 2D6. Pharmaceutical compositions are provided that can act as boosters to improve the pharmacokinetics, enhance the bioavailability, and enhance the therapeutic effect of drugs that undergo in vivo degradation by cytochrome P450 2D6 enzymes. |
priorityDate | 2007-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 382.